Quantitative imaging reveals heterogeneous growth dynamics and treatment-dependent residual tumor distributions in a three-dimensional ovarian cancer model

被引:60
作者
Celli, Jonathan P. [1 ]
Rizvi, Imran [1 ,2 ]
Evans, Conor L. [1 ]
Abu-Yousif, Adnan O. [1 ]
Hasan, Tayyaba [1 ]
机构
[1] Harvard Univ, Sch Med, Wellman Ctr Photomed, Massachusetts Gen Hosp, Boston, MA 02114 USA
[2] Dartmouth Coll, Thayer Sch Engn, Hanover, NH 03755 USA
基金
美国国家卫生研究院;
关键词
ovarian cancer; three-dimensional models; image processing; photodynamic therapy; carboplatin; INTRAPERITONEAL PHOTODYNAMIC THERAPY; PHASE-II TRIAL; IN-VIVO; EPITHELIAL ACINI; MALIGNANT BREAST; CELLS; CARCINOMATOSIS; FLUORESCENCE; SPHEROIDS; CULTURES;
D O I
10.1117/1.3483903
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Three-dimensional tumor models have emerged as valuable in vitro research tools, though the power of such systems as quantitative reporters of tumor growth and treatment response has not been adequately explored. We introduce an approach combining a 3-D model of disseminated ovarian cancer with high-throughput processing of image data for quantification of growth characteristics and cytotoxic response. We developed custom MATLAB routines to analyze longitudinally acquired dark-field microscopy images containing thousands of 3-D nodules. These data reveal a reproducible bimodal log-normal size distribution. Growth behavior is driven by migration and assembly, causing an exponential decay in spatial density concomitant with increasing mean size. At day 10, cultures are treated with either carboplatin or photodynamic therapy (PDT). We quantify size-dependent cytotoxic response for each treatment on a nodule by nodule basis using automated segmentation combined with ratiometric batch-processing of calcein and ethidium bromide fluorescence intensity data (indicating live and dead cells, respectively). Both treatments reduce viability, though carboplatin leaves micronodules largely structurally intact with a size distribution similar to untreated cultures. In contrast, PDT treatment disrupts micronodular structure, causing punctate regions of toxicity, shifting the distribution toward smaller sizes, and potentially increasing vulnerability to subsequent chemotherapeutic treatment. (C) 2010 Society of Photo-Optical Instrumentation Engineers. [DOI: 10.1117/1.3483903]
引用
收藏
页数:10
相关论文
共 30 条
[21]   In vitro three-dimensional modelling of human ovarian surface epithelial cells [J].
Lawrenson, K. ;
Benjamin, E. ;
Turmaine, M. ;
Jacobs, I. ;
Gayther, S. ;
Dafou, D. .
CELL PROLIFERATION, 2009, 42 (03) :385-393
[22]   Three-dimensional culture models of normal and malignant breast epithelial cells [J].
Lee, Genee Y. ;
Kenny, Paraic A. ;
Lee, Eva H. ;
Bissell, Mina J. .
NATURE METHODS, 2007, 4 (04) :359-365
[23]  
Limpert E, 2001, BIOSCIENCE, V51, P341, DOI 10.1641/0006-3568(2001)051[0341:LNDATS]2.0.CO
[24]  
2
[25]   Pharmaceutical management of ovarian cancer - Current status [J].
Markman, Maurie .
DRUGS, 2008, 68 (06) :771-789
[26]  
Molpus KL, 1996, CANCER RES, V56, P1075
[27]   Intraperitoneal photoimmunotherapy of ovarian carcinoma xenografts in nude mice using charged photoimmunoconjugates [J].
Molpus, KL ;
Hamblin, MR ;
Rizvi, I ;
Hasan, T .
GYNECOLOGIC ONCOLOGY, 2000, 76 (03) :397-404
[28]   ErbB2, but not ErbB1, reinitiates proliferation and induces luminal repopulation in epithelial acini [J].
Muthuswamy, SK ;
Li, DM ;
Lelievre, S ;
Bissell, MJ ;
Brugge, JS .
NATURE CELL BIOLOGY, 2001, 3 (09) :785-792
[29]   Blockade of tumor cell transforming growth factor-βs enhances cell cycle progression and sensitizes human breast carcinoma cells to cytotoxic chemotherapy [J].
Ohmori, T ;
Yang, JL ;
Price, JO ;
Arteaga, CL .
EXPERIMENTAL CELL RESEARCH, 1998, 245 (02) :350-359
[30]   In vivo high-resolution fluorescence microendoscopy for ovarian cancer detection and treatment monitoring [J].
Zhong, W. ;
Celli, J. P. ;
Rizvi, I. ;
Mai, Z. ;
Spring, B. Q. ;
Yun, S. H. ;
Hasan, T. .
BRITISH JOURNAL OF CANCER, 2009, 101 (12) :2015-2022